85 related articles for article (PubMed ID: 7463948)
1. Immunologic studies in IgA nephropathy.
Woodroffe AJ; Gormly AA; McKenzie PE; Wootton AM; Thompson AJ; Seymour AE; Clarkson AR
Kidney Int; 1980 Sep; 18(3):366-74. PubMed ID: 7463948
[TBL] [Abstract][Full Text] [Related]
2. CEA-containing immune complexes in sera of patients with colorectal and breast cancer--analysis of complexed immunoglobulin classes.
Fuchs C; Krapf F; Kern P; Hoferichter S; Jäger W; Kalden JR
Cancer Immunol Immunother; 1988; 26(2):180-4. PubMed ID: 3282655
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of circulating immune complexes in IgA nephropathy.
Matsumoto Y; Aryal RP; Heimburg-Molinaro J; Park SS; Wever WJ; Lehoux S; Stavenhagen K; van Wijk JAE; Van Die I; Chapman AB; Chaikof EL; Cummings RD
Sci Adv; 2022 Oct; 8(43):eabm8783. PubMed ID: 36306365
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, prospective, observational study to determine association of mesangial C1q deposition with renal outcomes in IgA nephropathy.
Tan L; Tang Y; Pei G; Zhong Z; Tan J; Zhou L; Wen D; Sheikh-Hamad D; Qin W
Sci Rep; 2021 Mar; 11(1):5467. PubMed ID: 33750830
[TBL] [Abstract][Full Text] [Related]
5. Intravenous administration of Streptococcus mutans induces IgA nephropathy-like lesions.
Naka S; Wato K; Misaki T; Ito S; Nagasawa Y; Nomura R; Matsumoto-Nakano M; Nakano K
Clin Exp Nephrol; 2020 Dec; 24(12):1122-1131. PubMed ID: 32909181
[TBL] [Abstract][Full Text] [Related]
6. The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.
Rizk DV; Maillard N; Julian BA; Knoppova B; Green TJ; Novak J; Wyatt RJ
Front Immunol; 2019; 10():504. PubMed ID: 30941137
[TBL] [Abstract][Full Text] [Related]
7. Renal Outcomes in Patients With IgA Nephropathy Undergoing Liver Transplant: A Retrospective Cohort Study.
Hommos MS; El-Zoghby ZM
Transplant Direct; 2017 Aug; 3(8):e193. PubMed ID: 28795144
[TBL] [Abstract][Full Text] [Related]
8. Proteins induced by telomere dysfunction are associated with human IgA nephropathy.
Lu YY; Yang X; Chen WQ; Ju ZY; Shou ZF; Jin J; Zhang XH; Chen JH; Jiang H
J Zhejiang Univ Sci B; 2014 Jun; 15(6):566-74. PubMed ID: 24903994
[TBL] [Abstract][Full Text] [Related]
9. Association of liver cirrhosis related IgA nephropathy with portal hypertension.
Kalambokis G; Christou L; Stefanou D; Arkoumani E; Tsianos EV
World J Gastroenterol; 2007 Nov; 13(43):5783-6. PubMed ID: 17963311
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy.
Wang J; Anders RA; Wu Q; Peng D; Cho JH; Sun Y; Karaliukas R; Kang HS; Turner JR; Fu YX
J Clin Invest; 2004 Mar; 113(6):826-35. PubMed ID: 15067315
[TBL] [Abstract][Full Text] [Related]
11. T-cell epitopes recognized within the 65,000 MW hsp in patients with IgA nephropathy.
Warr K; Fortune F; Namie S; Wilson A; Shinnick T; Van der Zee R; Williams G; Lehner T
Immunology; 1997 Jul; 91(3):399-405. PubMed ID: 9301529
[TBL] [Abstract][Full Text] [Related]
12. IgA nephropathy presenting clinicopathological features of acute post-streptococcal glomerulonephritis.
Okada K; Saitoh S; Sakaguchi Z; Zhang RJ; Kuhara T; Yasutomo K; Kuroda Y
Eur J Pediatr; 1996 Apr; 155(4):327-30. PubMed ID: 8777929
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of idiopathic IgA nephropathy.
Williams DG
Pediatr Nephrol; 1993 Jun; 7(3):303-11. PubMed ID: 8518104
[TBL] [Abstract][Full Text] [Related]
14. Low antibody affinity restricted to the IgA isotype in IgA nephropathy.
Layward L; Allen AC; Hattersley JM; Harper SJ; Feehally J
Clin Exp Immunol; 1994 Jan; 95(1):35-41. PubMed ID: 8287607
[TBL] [Abstract][Full Text] [Related]
15. IgA glomerular deposits in experimental cirrhosis.
Gormly AA; Smith PS; Seymour AE; Clarkson AR; Woodroffe AJ
Am J Pathol; 1981 Jul; 104(1):50-4. PubMed ID: 6973280
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of neutrophil migration by serum IgA from patients with IgA nephropathy.
Egido J; Sancho J; Lorente F; Fontan G
Clin Exp Immunol; 1982 Sep; 49(3):709-16. PubMed ID: 6756724
[TBL] [Abstract][Full Text] [Related]
17. Mesangial IgA nephropathies--steady progress.
Couser WG
West J Med; 1984 Jan; 140(1):89-91. PubMed ID: 6702197
[No Abstract] [Full Text] [Related]
18. Late development of purpura in a patient with glomerulonephritis.
Cybulsky AV; Jothy S; Seely JF
Can Med Assoc J; 1984 Jan; 130(2):149-52. PubMed ID: 6692193
[TBL] [Abstract][Full Text] [Related]
19. Experimental IgA nephropathy induced by oral immunization.
Emancipator SN; Gallo GR; Lamm ME
J Exp Med; 1983 Feb; 157(2):572-82. PubMed ID: 6681626
[TBL] [Abstract][Full Text] [Related]
20. Partial H (beta 1H) deficiency and glomerulonephritis in two families.
Wyatt RJ; Julian BA; Weinstein A; Rothfield NF; McLean RH
J Clin Immunol; 1982 Apr; 2(2):110-7. PubMed ID: 6461667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
